ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.04
1.04
Range Annuel
0.33
1.51
Changement quotidien
+10.64%
Changement Mensuel
+14.29%
Evolution sur 6 mois
+4.00%
Changement Annuel
+173.68%
Clôture Précédente
0.9 4
Open
1.0 4
Low
1.0 4
High
1.0 4
Volume
30
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 124.13 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.91
ratio cours/chiffre d'affaires
-169.59

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Nouvelles